SCOPUS 정보 검색 플랫폼

American Journal of Gastroenterology

Volumn 97, Issue 8, 2002, Pages 2147-2149

Fenofibrate treatment in patients with primary biliary cirrhosis [8]

(4) Ohira, Hiromasa a Sato, Yukio a Ueno, Takato b Sata, Michio b

a FUKUSHIMA MEDICAL UNIVERSITY (Japan)

b Division of Clinical Research Research Center for Innovative Cancer Therapy (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BEZAFIBRATE; FENOFIBRATE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN M; URSODEOXYCHOLIC ACID;

ADULT; AGED; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; LETTER; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0036678375 PISSN: 00029270 EISSN: None Source Type: Journal
DOI: 10.1016/S0002-9270(02)04301-0 Document Type: Letter

Times cited : (74)

References (13)

1
- 0023110737
- Primary biliary cirrhosis
- (1987) N Engl J Med , vol.316 , pp. 521-528
- Kaplan, M.M.¹

2
- 0032750057
- Bezafibrate may have a benefical effect in precirrhotic primary biliary cirrhosis
- (1999) Hepatol Res , vol.16 , pp. 12-18
- Iwasaki, S.¹ Tsuda, K.² Ueta, H.³

3
- 0033989267
- Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: A preliminary study
- (2000) Am J Gastroenterol , vol.95 , pp. 326-327
- Nakai, S.¹ Masaki, T.² Kurokohchi, K.³

4
- 0033636090
- A novel treatment for refractory primary biliary cirrhosis?
- (2000) Hepatogastroenterology , vol.47 , pp. 1518-1521
- Miyaguchi, S.¹ Ebinuma, H.² Imaeda, H.³

5
- 0033792659
- Bezafibrate in the treatment of primary biliary cirrhosis: Comparison with ursodeoxycholic acid
- (2000) Am J Gastroenterol , vol.95 , pp. 2990-2992
- Kurihara, T.¹ Niimi, A.² Maeda, A.³

6
- 0030985318
- Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay
- (1997) Mol Endocrinol , vol.11 , pp. 779-791
- Krey, G.¹ Braissant, O.² L'Horset, F.³

7
- 0029661982
- The PPARalpha-leukotriene B4 pathway to inflammation control
- (1996) Nature , vol.384 , pp. 39-43
- Devchand, P.R.¹ Keller, H.² Peters, J.M.³

8
- 0029922002
- Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse
- (1996) Biochem J , vol.314 , pp. 781-786
- Chianale, J.¹ Vollrath, V.² Wielandt, A.M.³

9
- 0023026497
- Effects of fenofibrate on plasma lipids. Double-blind, multicenter study in patients with type IIA or IIB hyperlipidemia
- (1986) Arteriosclerosis , vol.6 , pp. 670-678
- Brown, W.V.¹ Dujovne, C.A.² Farquhar, J.W.³

10
- 0028273352
- Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia
- (1994) Arch Intern Med , vol.154 , pp. 441-449
- Farnier, M.¹ Bonnefous, F.² Debbas, N.³ Irvine, A.⁴

11
- 0033998334
- The PPARs: From orphan receptors to drug discovery
- (2000) J Med Chem , vol.43 , pp. 527-550
- Willson, T.M.¹ Brown, P.J.² Sternbach, D.D.³ Henke, B.R.⁴

12
- 0022378103
- Comparative study of bezafibrate and fenofibrate in patients with primary hyperlipoproteinaemia
- (1985) Curr Med Res Opin , vol.9 , pp. 650-657
- Tesone, P.A.¹ Gladstein, J.² Acuna, A.M.³

13
- 0032169919
- Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway
- (1998) Toxicol Lett , vol.98 , pp. 13-23
- Edgar, A.D.¹ Tomkiewicz, C.² Costet, P.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.